We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$82.1B
AUM Growth
+$7.21B
Cap. Flow
+$2.14B
Cap. Flow %
2.6%
Top 10 Hldgs %
34.14%
Holding
3,101
New
616
Increased
843
Reduced
896
Closed
659

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$495M
2
SPOT icon
Spotify
SPOT
+$377M
3
HUM icon
Humana
HUM
+$350M
4
GS icon
Goldman Sachs
GS
+$324M
5
MRK icon
Merck
MRK
+$307M

Sector Composition

Rank Sector Weight
1 Technology 18.11%
2 Consumer Discretionary 14.61%
3 Healthcare 12.89%
4 Industrials 6.78%
5 Financials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCSA icon
476
Comcast
CMCSA
$79.1B
$21.4M 0.03%
+513,373
New +$20.3M
RYTM icon
477
Rhythm Pharmaceuticals
RYTM
$7B
$21.3M 0.03%
406,615
+299,806
+281% +$14.4M
DDS icon
478
Dillards
DDS
$8.87B
$21.3M 0.03%
+55,401
New +$21.1M
OC icon
479
Owens Corning
OC
$11.5B
$21.2M 0.03%
+120,226
New +$20.2M
BBIO icon
480
BridgeBio Pharma
BBIO
$16.5B
$21.2M 0.03%
833,236
+802,387
+2,601% +$21.1M
BKR icon
481
Baker Hughes
BKR
$56.8B
$21.1M 0.03%
584,068
+523,287
+861% +$18.4M
KLAC icon
482
KLA
KLAC
$275B
$20.9M 0.03%
+270,280
New +$21.2M
EBS icon
483
Emergent Biosolutions
EBS
$375M
$20.8M 0.03%
2,494,584
+1,951,771
+360% +$17.7M
UE icon
484
Urban Edge Properties
UE
$2.94B
$20.6M 0.03%
961,553
-84,811
-8% -$1.71M
STOK icon
485
Stoke Therapeutics
STOK
$1.82B
$20.5M 0.03%
1,670,733
+509,696
+44% +$7.22M
IYR icon
486
CALL
iShares US Real Estate ETF
IYR
$4.59B
$20.5M 0.03%
+201,100
New +$19.4M
TEL icon
487
TE Connectivity
TEL
$58.8B
$20.4M 0.02%
135,123
-230,931
-63% -$34.6M
PRU icon
488
Prudential Financial
PRU
$41.7B
$20.4M 0.02%
168,138
+165,738
+6,906% +$19.6M
MU icon
489
CALL
Micron Technology
MU
$1.04T
$20.4M 0.02%
196,300
+164,800
+523% +$17.2M
EIX icon
490
Edison International
EIX
$30.7B
$20.3M 0.02%
+233,584
New +$19M
WAT icon
491
Waters Corp
WAT
$36.8B
$20.3M 0.02%
56,338
+24,299
+76% +$7.91M
QLYS icon
492
Qualys
QLYS
$4.84B
$20.2M 0.02%
157,502
+127,582
+426% +$16.8M
CWK icon
493
Cushman & Wakefield Ltd
CWK
$2.98B
$20.1M 0.02%
1,475,262
-777,518
-35% -$9.81M
EWZ icon
494
PUT
iShares MSCI Brazil ETF
EWZ
$9.05B
$19.9M 0.02%
675,400
-507,000
-43% -$14.7M
CATX icon
495
Perspective Therapeutics
CATX
$332M
$19.9M 0.02%
1,490,791
+206,849
+16% +$2.75M
HCP
496
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$19.8M 0.02%
586,019
+247,312
+73% +$8.34M
AMD icon
497
PUT
Advanced Micro Devices
AMD
$851B
$19.8M 0.02%
120,700
+26,800
+29% +$4.07M
WDC icon
498
Western Digital
WDC
$179B
$19.7M 0.02%
382,241
-556,277
-59% -$28.1M
EGP icon
499
EastGroup Properties
EGP
$11.5B
$19.7M 0.02%
+105,499
New +$19.4M
CZR icon
500
Caesars Entertainment
CZR
$6.1B
$19.7M 0.02%
+472,107
New +$17.7M

Similar funds

Marshall Wace's Q3 2024 Portfolio in Review

As of Q3 2024, Marshall Wace held 3,101 positions worth $82.1B, up 9.6% from $74.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Marshall Wace's Q3 2024 filing shows 616 new, 843 increased, 896 reduced and 659 closed positions. Its largest new stake was Texas Instruments: 1,008,812 shares worth $208M. The largest sale was Costco, an estimated $495M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q3 2024 buy was Texas Instruments: 1,008,812 shares worth $208M.
  • Marshall Wace added most to Tesla in Q3 2024, an estimated $700M increase.
  • Marshall Wace's biggest Q3 2024 reduction was Costco, cutting an estimated $495M.
  • Marshall Wace fully exited Shopify in Q3 2024, selling an estimated $209M.
  • Marshall Wace's ten largest holdings make up 34% of its $82.1B portfolio in Q3 2024.
  • Marshall Wace opened 616 new positions and closed 659 in Q3 2024.
  • Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $82.1B.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.